summary

Little known outside his native Australia, David Stove was one of the most illuminating and brilliant philo-sophical essayists of the postwar era. A fearless at-tacker of intellectual and cultural orthodoxies, Stove left powerful critiques of scientific irrationalism, Dar-winian theories of human behavior, and philosophi-cal idealism. He was also an occasional essayist of considerable charm and polemical snap. Stove’s writ-ing is both rigorous and immensely readable. It is, in the words of Roger Kimball, “an invigorating blend of analytic lucidity, mordant humor, and an amount of common sense too great to be called ‘common.'” Against the Idols of the Age brings together a repre-sentative selection of Stove’s writing and is an ideal introduction to his work.The book opens with some of Stove’s most impor-tant attacks on irrationalism in the philosophy of sci-ence. He exposes the roots of this fashionable attitude, tracing it through writers like Paul Feyerabend andThomas Kuhn to Karl Popper. Stove was a born controversialist, so it is not surpris-ing that when he turned his attention to contemporary affairs he said things that are politically incorrect. The topical essays that make up the second part of the book show Stove at his most withering and combative. Whether the subject is race, femi-nism, the Enlightenment, or the demand for “non-coercive philosophy,” Stove is on the mark with a battery of impressive arguments expressed in sharp, uncompromis-ing prose. Against the Idols of the Age concludes with a generous sampling of his blistering attacks on Darwinism.David Stove’s writings are an undiscovered treasure. Although readers may dis-agree with some of his opinions, they will find it difficult to dismiss his razor-sharp arguments. Against the Idols of the Age is the first book to make the full range of this important thinker available to the general reader.

Let's start with the truth!

Support the Broken Science Initiative.
Subscribe today →

Leave A Comment

recent posts

    At the 2026 Unbreakable Health Retreat in Miami, Emily Kaplan hosted a panel with Bob Kaplan, Professor Thomas Seyfried, and Dr. Derek Lee on what it means to treat cancer as a metabolic disease. They discussed the glucose-ketone index (GKI), nutritional ketosis, and strategies aimed at restricting the fuels cancer cells depend on while considering how metabolic therapy can fit alongside standard cancer treatment.

    The conversation also addressed the practical realities patients face when trying to pursue a metabolic approach within the conventional oncology system, including questions about nutrition, repurposed drugs, inherited cancer risk, and how to evaluate different treatment options. Seyfried and Lee connected these clinical questions back to mitochondrial dysfunction, fermentation, and the metabolic vulnerabilities that may offer additional targets for cancer treatment.

    An abbreviated version of this discussion is available here, for free.

    At the 2026 Unbreakable Health Retreat in Miami, Professor Thomas Seyfried presented the case that cancer is fundamentally a mitochondrial metabolic disease rather than primarily a genetic one. He contrasts the dominant somatic mutation theory with a metabolic model in which impaired mitochondrial respiration drives a shift toward fermentation, dysregulated cell growth, and the mutations commonly associated with cancer.

    Citing the work of Otto Warburg and research from his lab at Boston College, Seyfried explains how cancer cells rely heavily on fermentable fuels—particularly glucose and glutamine—and why mitochondrial dysfunction sits upstream of many of the genetic abnormalities seen in tumors. He also discusses reactive oxygen species, altered cellular signaling, and the role of mitochondria in regulating cell growth and behavior.

    The presentation then turns to the therapeutic implications of this model. Seyfried explains strategies aimed at placing tumor cells under metabolic stress by restricting the fuels they depend on, including ketogenic metabolic therapy and approaches targeting glucose and glutamine. For Seyfried, the therapeutic target follows directly from the biology: restrict the fuels cancer cells depend on, exploit their metabolic weaknesses, and treat mitochondrial dysfunction as the central feature of the disease.

    An abbreviated version of this discussion is available here, for free.

    MetFix and BSI Members can view the full 54-minute video.

  • Metabolic health, medical education, and the case for bringing clinicians and coaches together